Madrigal Pharmaceuticals, Inc. Common Stock (NASDAQ: MDGL) last traded at $516.74, down 0.45% on the session. The quote above updates while this page is open; the figures below are drawn from Madrigal Pharmaceuticals, Inc. Common Stock’s own filings and are restated only when a new one is published.
Madrigal Pharmaceuticals, Inc. Common Stock trades on NASDAQ under the ticker MDGL. Its market capitalisation is $11.94 billion.
Valuation measures for Madrigal Pharmaceuticals, Inc. Common Stock, derived from the latest quote and its most recent SEC filing.
| Market cap | $11.94B |
|---|---|
| Enterprise value | $12.37B |
| Price / sales | 9.30 |
| Price / book | 22.80 |
| Beta | 0.33 |
Trailing-twelve-month figures tagged in Madrigal Pharmaceuticals, Inc. Common Stock's XBRL filings with the SEC.
| Revenue (TTM) | $1.28B |
|---|---|
| Net income (TTM) | -$325.10M |
| EPS (TTM) | -$11.28 |
| Operating margin | -25.13% |
| Return on equity | -62.07% |
| Cash | $292.73M |
Range and volume for MDGL over the past 52 weeks.
| 52-week high | $615.00 |
|---|---|
| 52-week low | $393.61 |
| Volume | 178.3K |
| Average volume | 359.9K |
| Previous close | $519.09 |
A dash means FurlPay does not have that figure, not that it is zero. Nothing on this page is investment advice or a recommendation to buy or sell any security. Figures are provided for information only and may be delayed or restated.